Growth and health outcomes at school age in HIV-exposed, uninfected Zambian children: Follow-up of two cohorts studied in infancy

BMC Pediatrics

Volumn 15, Issue 1, 2015, Pages

  Nicholson, Laura ^a   Chisenga, Molly ^b   Siame, Joshua ^b   Kasonka, Lackson ^b   Filteau, Suzanne ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY TEACHING HOSPITAL   (Zambia)

Author keywords

Body composition; Growth; HIV exposure; School performance

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; GLUCOSE; HEMOGLOBIN; HEMOGLOBIN A1C; NEVIRAPINE; BIOLOGICAL MARKER;

ACADEMIC ACHIEVEMENT; ACUTE DISEASE; ARTICLE; BLOOD PRESSURE; BODY FAT; BODY MASS; CHILD; CHILD GROWTH; CHILD HEALTH; CHRONIC DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HIP CIRCUMFERENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SKINFOLD THICKNESS; SOCIOECONOMICS; THIGH CIRCUMFERENCE; VERTICAL TRANSMISSION; ZAMBIAN; ACHIEVEMENT; ANTHROPOMETRY; BODY COMPOSITION; CHILD DEVELOPMENT; FOLLOW UP; HEALTH STATUS; PREGNANCY; PREGNANCY COMPLICATION; PRENATAL EXPOSURE; ZAMBIA;

ACHIEVEMENT; ANTHROPOMETRY; BIOMARKERS; BODY COMPOSITION; CHILD; CHILD DEVELOPMENT; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS; HIV INFECTIONS; HUMANS; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL EXPOSURE DELAYED EFFECTS; SOCIOECONOMIC FACTORS; ZAMBIA;

EID: 84931082526     PISSN: None     EISSN: 14712431     Source Type: Journal    
DOI: 10.1186/s12887-015-0386-8     Document Type: Article

References (30)

1. Chen JY, Ribaudo HJ, Souda S, Parekh N, Ogwu A, Lockman S, et al. Highly active antiretroviral therapy and adverse birth outcomes among HIV-infected women in Botswana. J Infect Dis. 2012;206(11):1695-705.
2. Filteau S, Baisley K, Chisenga M, Kasonka L, Gibson R, CIGNIS Study Team. Provision of micronutrient-fortified food from 6 months of age does not permit HIV-exposed, uninfected Zambian children to catch up in growth to HIV-unexposed children: a randomised controlled trial. J AIDS. 2011;56:166-75.
3. Makasa M, Kasonka L, Chisenga M, Sinkala M, Chintu C, Tomkins A, et al. Early growth of infants of HIV-infected and uninfected Zambian women. Trop Med Int Health. 2007;12(5):594-602.
4. Filteau S. The HIV-exposed, uninfected African child. Trop Med Int Health. 2009;14:276-87.
5. Slyker JA, Patterson J, Ambler G, Richardson BA, Maleche-Obimbo E, Bosire R, et al. Correlates and outcomes of preterm birth, low birth weight, and small for gestational age in HIV-exposed uninfected infants. BMC Pregnancy Childbirth. 2014;14:7.
6. Cotton MF, Schaaf HS, Lottering G, Weber HL, Coetzee J, Nachman SA. Tuberculosis exposure in HIV-exposed infants in a high-prevalence setting. Int J Tuberc Lung Dis. 2008;12(2):225-7.
7. Gompels UA, Larke N, Sanz-Ramos M, Bates M, Musonda K, Manno D, et al. Human cytomegalovirus infant infection adversely affects growth and development in maternally HIV-exposed and unexposed infants in Zambia. Clin Infect Dis. 2012;54(3):434-42.
8. Afran L, Garcia Knight M, Nduati E, Urban BC, Heyderman RS, Rowland-Jones SL. HIV-exposed uninfected children: a growing population with a vulnerable immune system? Clin Exp Immunol. 2014;176(1):11-22.
9. Chisenga M, Kasonka L, Makasa M, Sinkala M, Chintu C, Kaseba C, et al. Factors affecting the duration of exclusive breastfeeding among HIV-infected and-uninfected women in Lusaka, Zambia. J Hum Lact. 2005;21(3):266-75.
10. Chilenje Infant Growth Nutrition and Infection (CIGNIS) Study Team. Micronutrient fortification to improve growth and health of maternally HIV-unexposed and exposed Zambian infants: a randomised controlled trial. PLoS ONE. 2010;5(6):e11165.
11. Kasonka L, Makasa M, Marshall T, Chisenga M, Sinkala M, Chintu C, et al. Risk factors for subclinical mastitis among HIV-infected and uninfected women in Lusaka, Zambia. Paediatr Perinat Epidemiol. 2006;20(5):379-91.
12. Koyanagi A, Humphrey JH, Ntozini R, Nathoo K, Moulton LH, Iliff P, et al. Morbidity among human immunodeficiency virus-exposed but uninfected, human immunodeficiency virus-infected, and human immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy. Pediatr Infect Dis J. 2011;30(1):45-51.
13. Prendergast AJ, Humphrey JH. The stunting syndrome in developing countries. Paediatr Int Child Health. 2014;34(4):250-65.
14. Manno D, Kowa PK, Bwalya HK, Siame J, Grantham-McGregor S, Baisley K, et al. Rich micronutrient fortification of locally produced infant food does not improve mental and motor development of Zambian infants: a randomised controlled trial. Br J Nutr. 2012;107(4):556-66.
15. McDonald CM, Manji KP, Kupka R, Bellinger DC, Spiegelman D, Kisenge R, et al. Stunting and wasting are associated with poorer psychomotor and mental development in HIV-exposed Tanzanian infants. J Nutr. 2013;143(2):204-14.
16. Casale D, Desmond C, Richter L. The association between stunting and psychosocial development among preschool children: a study using the South African Birth to Twenty cohort data. Child Care Health Dev. 2014;40(6):900-10.
17. Newell ML, Borja MC, Peckham C, European CS. Height, weight, and growth in children born to mothers with HIV-1 infection in Europe. Pediatrics. 2003;111(1):e52-60.
18. Chisenga M, Siame J, Baisley K, Kasonka L, Filteau S. Determinants of infant feeding choices by Zambian mothers: a mixed quantitative and qualitative study. Matern Child Nutr. 2011;7:148-59.
19. Gibson RS. Principles of Nutritional Assessment. 2nd ed. Oxford: Oxford University Press; 2005.
20. World Health Organization. Growth reference data for 5-19 years. 2007. Available from: http://www.who.int/growthref/en/.
21. Filmer D, Pritchett L. Estimating wealth effects without expenditure data-or tears: an application to educational enrolments in states of India. Demography. 2001;38:115-32.
22. Sterne JA, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ. 2009;338:b2393.
23. Hankin C, Thorne C, Peckham C, Newell ML. The health and social environment of uninfected infants born to HIV-infected women. AIDS Care. 2004;16(3):293-303.
24. Isanaka S, Duggan C, Fawzi WW. Patterns of postnatal growth in HIV-infected and HIV-exposed children. Nutr Rev. 2009;67(6):343-59.
25. Van Rie A, Mupuala A, Dow A. Impact of the HIV/AIDS epidemic on the neurodevelopment of preschool-aged children in Kinshasa, Democratic Republic of the Congo. Pediatrics. 2008;122(1):e123-8.
26. Msellati P, Lepage P, Hitimana DG, Van Goethem C, Van de Perre P, Dabis F. Neurodevelopmental testing of children born to human immunodeficiency virus type 1 seropositive and seronegative mothers: a prospective cohort study in Kigali, Rwanda. Pediatrics. 1993;92(6):843-8.
27. Ngoma MS, Hunter JA, Harper JA, Church PT, Mumba S, Chandwe M, et al. Cognitive and language outcomes in HIV-uninfected infants exposed to combined antiretroviral therapy in utero and through extended breast-feeding. AIDS. 2014;28 Suppl 3:S323-30.
28. Drotar D, Olness K, Wiznitzer M, Guay L, Marum L, Svilar G, et al. Neurodevelopmental outcomes of Ugandan infants with human immunodeficiency virus type 1 infection. Pediatrics. 1997;100(1):E5.
29. Bagenda D, Nassali A, Kalyesubula I, Sherman B, Drotar D, Boivin MJ, et al. Health, neurologic, and cognitive status of HIV-infected, long-surviving, and antiretroviral-naive Ugandan children. Pediatrics. 2006;117(3):729-40.
30. Rosenthal LS, Fowler KB, Boppana SB, Britt WJ, Pass RF, Schmid SD, et al. Cytomegalovirus shedding and delayed sensorineural hearing loss: results from longitudinal follow-up of children with congenital infection. Pediatr Infect Dis J. 2009;28(6):515-20.